日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

When Covering and Discovering Are at Odds: How the Logic of US Health Insurance Undercuts the Promise and Equity of Precision Medicine for People with Hereditary Cancer Risks

当保障与发现相互矛盾时：美国医疗保险的逻辑如何削弱了精准医疗对具有遗传性癌症风险人群的承诺和公平性

期刊:
影响因子:
doi:10.1215/03616878-12317993
Mrig, Emily Hammad; Schlesinger, Mark; Weiss, Jennifer M; Pandhi, Nancy; Smith, Katherine Clegg; Jacobson, Nora; Grob, Rachel
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Service Outcomes for Germline Test Delivery for Patients With Metastatic Prostate Cancer

转移性前列腺癌患者生殖系检测服务的成果

期刊:Jama Network Open
影响因子:
doi:10.1001/jamanetworkopen.2025.60152
Scheuner, Maren T; Hoggatt, Katherine J; Sales, Paloma; Zhang, Ning; Lerner, Barbara; Danowski, Morgan E; Osha, Margaret; Sokoloff, Abby; Mrig, Emily Hammad; Kohlmann, Wendy; McWhirter, Gina; Kelley, Michael J
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Financial assistance programs for genetic testing: Effective, ethical, and sustainable pathways to improving access disparities?

基因检测经济援助计划：改善获取途径不平等现象的有效、合乎伦理且可持续的途径？

期刊:Genetics in Medicine
影响因子:6.2
doi:10.1016/j.gim.2025.101417
Mrig, Emily Hammad; Phillips, Kathryn A; Schlesinger, Mark
发表日期：2025
文献求助 收藏

Extending the case for a "health disparities research industrial complex": A response to Ezell

进一步论证“健康差异研究产业综合体”：对埃泽尔的回应

期刊:Social Science & Medicine
影响因子:5
doi:10.1016/j.socscimed.2024.116622
Mrig, Emily Hammad; Spencer, Karen Lutfey
发表日期：2024
文献求助 收藏